Search details
1.
Real-world data on treatment outcomes in EGFR-mutant non-small-cell lung cancer patients receiving osimertinib in second or further lines.
Future Oncol
; 17(19): 2513-2527, 2021 Jul.
Article
in English
| MEDLINE | ID: mdl-33988036
2.
Infections and Immunotherapy in Lung Cancer: A Bad Relationship?
Int J Mol Sci
; 22(1)2020 Dec 22.
Article
in English
| MEDLINE | ID: mdl-33375194
3.
From Diagnostic-Therapeutic Pathways to Real-World Data: A Multicenter Prospective Study on Upfront Treatment for EGFR-Positive Non-Small Cell Lung Cancer (MOST Study).
Oncologist
; 24(6): e318-e326, 2019 06.
Article
in English
| MEDLINE | ID: mdl-30846513
4.
Responding to the challenges of international collaborations between the east and the west - report of the first JCOG-EORTC symposium and a perspective from young JCOG and EORTC investigators.
Jpn J Clin Oncol
; 49(1): 96-99, 2019 Jan 01.
Article
in English
| MEDLINE | ID: mdl-30395275
5.
Time to progression ratio in cancer patients enrolled in early phase clinical trials: time for new guidelines?
Br J Cancer
; 119(8): 937-939, 2018 10.
Article
in English
| MEDLINE | ID: mdl-30327567
6.
INTEGRATED CARE PATHWAYS IN LUNG CANCER: A QUALITY IMPROVEMENT PROJECT.
Int J Technol Assess Health Care
; 34(1): 3-9, 2018 Jan.
Article
in English
| MEDLINE | ID: mdl-29405098
7.
Exercise for counteracting post-acute COVID-19 syndrome in patients with cancer: an old but gold strategy?
Acta Oncol
; 61(3): 388-392, 2022 03.
Article
in English
| MEDLINE | ID: mdl-34854782
8.
Perioperative Treatment Strategies in EGFR-Mutant Early-Stage NSCLC: Current Evidence and Future Challenges.
J Thorac Oncol
; 19(2): 199-215, 2024 02.
Article
in English
| MEDLINE | ID: mdl-37783386
9.
Sterotactic Ablative Radiotherapy in a Multicentric Series of Oligometastatic SCLC: The SAMOS Cohort.
Clin Lung Cancer
; 25(2): 151-158, 2024 03.
Article
in English
| MEDLINE | ID: mdl-38052684
10.
Association Between Lung Immune Prognostic Index and Durvalumab Consolidation Outcomes in Patients With Locally Advanced Non-Small-Cell Lung Cancer.
Clin Lung Cancer
; 25(3): 233-243.e8, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38105153
11.
A computational index derived from whole-genome copy number analysis is a novel tool for prognosis in early stage lung squamous cell carcinoma.
Genomics
; 99(1): 18-24, 2012 Jan.
Article
in English
| MEDLINE | ID: mdl-22050995
12.
HER-2 Expression in Brain Metastases from Colorectal Cancer and Corresponding Primary Tumors: A Case Cohort Series.
Int J Mol Sci
; 14(2): 2370-87, 2013 Jan 24.
Article
in English
| MEDLINE | ID: mdl-23348930
13.
Delta-like ligand 3 (DLL3): an attractive actionable target in tumors with neuroendocrine origin.
Expert Rev Anticancer Ther
; 22(6): 597-603, 2022 06.
Article
in English
| MEDLINE | ID: mdl-35477310
14.
SCLC Treatment in the Immuno-Oncology Era: Current Evidence and Unmet Needs.
Front Oncol
; 12: 840783, 2022.
Article
in English
| MEDLINE | ID: mdl-35494084
15.
Study Design and Rationale for Espera Trial: A Multicentre, Randomized, Phase II Clinical Trial Evaluating the Potential Efficacy of Adding SBRT to Pembrolizumab-Pemetrexed Maintenance in Responsive or Stable Advanced Non-Squamous NSCLC After Chemo-Immunotherapy Induction.
Clin Lung Cancer
; 23(3): e269-e272, 2022 05.
Article
in English
| MEDLINE | ID: mdl-34470722
16.
Selpercatinib in RET-fusion positive metastatic non-small cell lung cancer: achievements and gray areas.
Expert Rev Anticancer Ther
; 22(8): 785-794, 2022 08.
Article
in English
| MEDLINE | ID: mdl-35726802
17.
Maintenance or consolidation therapy in small-cell lung cancer: an updated systematic review and meta-analysis.
Semin Oncol
; 49(5): 389-393, 2022 10.
Article
in English
| MEDLINE | ID: mdl-36184311
18.
Exercise in lung Cancer, the healthcare providers opinion (E.C.H.O.): Results of the EORTC lung cancer Group (LCG) survey.
Lung Cancer
; 169: 94-101, 2022 07.
Article
in English
| MEDLINE | ID: mdl-35691097
19.
Durvalumab consolidation in patients with unresectable stage III non-small cell lung cancer with driver genomic alterations.
Eur J Cancer
; 167: 142-148, 2022 05.
Article
in English
| MEDLINE | ID: mdl-35307254
20.
Immunotherapy in malignant pleural mesothelioma: a review of literature data.
Transl Lung Cancer Res
; 10(6): 2988-3000, 2021 Jun.
Article
in English
| MEDLINE | ID: mdl-34295692